Literature DB >> 24331841

Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.

Kyung-Ju Kim1, Kyu Sang Lee2, Hwa Jin Cho2, Young Hoon Kim2, Han Kwang Yang3, Woo Ho Kim2, Gyeong Hoon Kang4.   

Abstract

Microsatellite instability (MSI)-high gastric cancers (GC) have better prognosis and higher levels of tumor-infiltrating lymphocytes (TIL) compared with MSI-low or MSI-stable GCs. TILs are part of the adaptive immune response against tumor growth and are associated with improved prognosis in GCs. The aim of this study was to investigate the prognostic significance of CD8+ and FoxP3+ TILs in MSI-high GCs and their relationships with various clinicopathologic characteristics. Intratumoral intraepithelial CD8+ and FoxP3+ TILs were assessed in 99 cases of MSI-high GCs using a computerized image analysis system. TILs were grouped into low- and high-density groups and were analyzed for their relationships with clinicopathologic parameters. A low density was closely associated with a higher TNM stage (P = .040) and invasion depth (P = .044) and more frequent lymphatic and vascular invasion (P = .033 and .015, respectively). GCs with high-density CD8+ or FoxP3+ TILs showed significantly higher overall survival rates than those of GCs with low-density CD8+ or FoxP3+ TILs (P = .017 and .013, respectively, Kaplan-Meier test). In multivariate survival analysis, a high density of FoxP3+ TILs was significantly associated with improved overall survival (P = .027; hazard ratio, 0.269), and the combinatorial status of CD8+ and FoxP3+ TIL density was an independent prognostic factor (P = .003). Our results demonstrate that higher densities of both intratumoral CD8+ and FoxP3+ TILs are associated with good prognosis, suggesting a synergistic activity of these 2 subsets that can be used as an independent prognostic factor in MSI-high GCs.
© 2014.

Entities:  

Keywords:  Gastric cancer; Microsatellite instability; Tumor infiltrating lymphocytes

Mesh:

Substances:

Year:  2013        PMID: 24331841     DOI: 10.1016/j.humpath.2013.09.004

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  56 in total

Review 1.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

Review 2.  Immunological battlefield in gastric cancer and role of immunotherapies.

Authors:  Minyu Wang; Rita A Busuttil; Sharon Pattison; Paul J Neeson; Alex Boussioutas
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

3.  Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features.

Authors:  Kyung-Ju Kim; Hae Yoen Jung; Mee-Hye Oh; Hyundeuk Cho; Ji-Hye Lee; Hyun Ju Lee; Si-Hyong Jang; Moon Soo Lee
Journal:  J Gastric Cancer       Date:  2015-09-30       Impact factor: 3.720

4.  Is Adjuvant Chemotherapy Necessary for Patients with Deficient Mismatch Repair Gastric Cancer?-Autophagy Inhibition Matches the Mismatched.

Authors:  Chun-Yi Tsai; Tien-An Lin; Shih-Chiang Huang; Jun-Te Hsu; Chun-Nan Yeh; Tse-Ching Chen; Cheng-Tang Chiu; Jen-Shi Chen; Ta-Sen Yeh
Journal:  Oncologist       Date:  2020-02-14

Review 5.  The functional and prognostic implications of regulatory T cells in colorectal carcinoma.

Authors:  Xinhai Zhang; Sonia Kelaria; Justin Kerstetter; Jun Wang
Journal:  J Gastrointest Oncol       Date:  2015-06

6.  Intratumoral density of regulatory T cells is a predictor of host immune response and chemotherapy response in colorectal cancer.

Authors:  Masanori Oshi; Joy Sarkar; Rongrong Wu; Yoshihisa Tokumaru; Li Yan; Kazuya Nakagawa; Atsushi Ishibe; Ryusei Matsuyama; Itaru Endo; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

7.  An immunosuppressive scoring system to predict recurrence and assist in decision regarding postoperative adjuvant treatment in gastric cancer.

Authors:  Jiabin Wang; Qingzhu Qiu; Ningzi Lian; Huagen Wang; Qiaoling Zheng; Yinghong Yang; Yubin Ma; Yajun Zhao; Ping Li; Jianxian Lin; Jun Lu; Qiyue Chen; Longlong Cao; Mi Lin; Changming Huang; Jianwei Xie
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942

8.  Expression of Helios in gastric tumor cells predicts better survival in gastric cancer patients.

Authors:  Wei-Ming Chen; Cheng-Shyong Wu; Jing-Lan Liu; Chia-Ming Yeh; Libby Tseng; Hao-Chun Huang; Pey-Jium Chang; Shu-Fen Wu
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-30       Impact factor: 4.553

9.  Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy.

Authors:  Sumi Yun; Jiwon Koh; Soo Kyung Nam; Yoonjin Kwak; Sang-Hoon Ahn; Joong Do Park; Hyung-Ho Kim; Woo Ho Kim; Hye Seung Lee
Journal:  Cancer Immunol Immunother       Date:  2020-08-12       Impact factor: 6.968

10.  Genetic Variants in the Regulatory T cell-Related Pathway and Colorectal Cancer Prognosis.

Authors:  Sonja Neumeyer; Xinwei Hua; Petra Seibold; Lina Jansen; Axel Benner; Barbara Burwinkel; Niels Halama; Sonja I Berndt; Amanda I Phipps; Lori C Sakoda; Robert E Schoen; Martha L Slattery; Andrew T Chan; Manish Gala; Amit D Joshi; Shuji Ogino; Mingyang Song; Esther Herpel; Hendrik Bläker; Matthias Kloor; Dominique Scherer; Alexis Ulrich; Cornelia M Ulrich; Aung K Win; Jane C Figueiredo; John L Hopper; Finlay Macrae; Roger L Milne; Graham G Giles; Daniel D Buchanan; Ulrike Peters; Michael Hoffmeister; Hermann Brenner; Polly A Newcomb; Jenny Chang-Claude
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-10-02       Impact factor: 4.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.